Loading organizations...
Tourbillon Global Ventures was a venture capital firm operating out of New York, New York. It provided investment capital with a specialized focus on companies within the biotechnology sector. The firm's approach centered on identifying and nurturing innovative early-stage ventures in the life sciences.
The firm was established in 2015, originating from a strategic initiative to support nascent companies in the burgeoning field of biotechnology. Its foundation reflected a commitment to fostering scientific advancement through targeted financial backing. This establishment marked a dedicated effort to engage with the unique challenges and opportunities present in biological innovation.
Tourbillon Global Ventures primarily served biotechnology startups requiring early-stage funding for research and development. Its mission involved accelerating the growth and commercial viability of these scientific enterprises. The firm aimed to contribute to significant breakthroughs by empowering innovators to bring new solutions to the market.
Tourbillon Global Ventures has 1 tracked investment across 1 company. The latest tracked deal is $71.0M Series D in REGENXBIO in May 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2015 | REGENXBIO | $71.0M Series D | Venrock, Vivo Capital, Brookside Capital | ARCH Venture Partners, Canaan Partners, Cormorant Asset Management, Deerfield Management, Foresite Capital, F Prime Capital, Janus Henderson Investors, Jennison Associates, Perceptive Advisors, QVT, RTW Investments, Sectoral Asset Management |
